Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

A single injection of a healthy gene allowed blind children to recognize objects, shapes, and even read — offering hope for ...

CompareNetworks is proud to announce the publication of the first issue of Cell & Gene Therapy Review, marking a significant ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

By Sneha S K (Reuters) -Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital ...

Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...

Sensorion's Audiogene Phase I/II trial of the SENS-501 gene therapy programme has received a favourable recommendation from ...

The vision of one child with AIPL1-associated severe retinal dystrophy improved from light perception to naming his favourite ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic ...